{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:47:18Z","timestamp":1794620838282,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI162684"],"award-info":[{"award-number":["R01AI162684"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI153487"],"award-info":[{"award-number":["R21AI153487"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI178367"],"award-info":[{"award-number":["R21AI178367"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pyroptosis is a cell death process that causes inflammation and contributes to numerous diseases. Pyroptosis is mediated by caspase-1 family proteases that cleave the pore-forming protein gasdermin D, causing plasma membrane rupture and release of pathogenic cellular contents. We previously identified muscimol as a small molecule that prevents plasma membrane rupture during pyroptosis via an unidentified mechanism. Here, we show that muscimol has reversible activity to prevent cellular lysis without affecting earlier pyroptotic events. Although muscimol is a well-characterized agonist for neuronal GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptors, muscimol protection is not altered by GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor antagonists or recapitulated by other GABA\n                    <jats:sub>A<\/jats:sub>\n                    agonists, suggesting that muscimol acts via a novel mechanism. We find that muscimol blocks oligomerization of ninjurin-1, which is required for plasma membrane rupture downstream of gasdermin D pore formation. Our structure-activity relationship studies reveal distinct molecular determinants defining inhibition of pyroptotic lysis compared to GABA\n                    <jats:sub>A<\/jats:sub>\n                    binding. In addition, we demonstrate that muscimol reduces lethality during LPS-induced septic shock. Together, these findings demonstrate that ninjurin-1-mediated plasma membrane rupture can be pharmacologically modulated and pave the way toward identification of therapeutic strategies for pathologic conditions associated with pyroptosis.\n                  <\/jats:p>","DOI":"10.1038\/s42003-023-05354-4","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T05:02:13Z","timestamp":1696482133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Muscimol inhibits plasma membrane rupture and ninjurin-1(NINJ1) oligomerization during pyroptosis"],"prefix":"10.1038","volume":"6","author":[{"given":"Andreas B.","family":"den Hartigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy P.","family":"Loomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Fr\u00f8lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1705-0103","authenticated-orcid":false,"given":"Susan L.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"5354_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri.2016.147","volume":"17","author":"I Jorgensen","year":"2017","unstructured":"Jorgensen, I., Rayamajhi, M. & Miao, E. A. Programmed cell death as a defence against infection. Nat. Rev. Immunol. 17, 151\u2013164 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"5354_CR2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.intimp.2018.12.028","volume":"67","author":"C Jia","year":"2019","unstructured":"Jia, C. et al. Role of pyroptosis in cardiovascular diseases. Int. Immunopharmacol. 67, 311\u2013318 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"5354_CR3","doi-asserted-by":"crossref","first-page":"e12563","DOI":"10.1111\/cpr.12563","volume":"52","author":"Z Zhaolin","year":"2019","unstructured":"Zhaolin, Z., Guohua, L., Shiyuan, W. & Zuo, W. Role of pyroptosis in cardiovascular disease. Cell Prolif. 52, e12563 (2019).","journal-title":"Cell Prolif."},{"key":"5354_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bpa.12476","volume":"27","author":"J Barrington","year":"2017","unstructured":"Barrington, J., Lemarchand, E. & Allan, S. M. A brain in flame; do inflammasomes and pyroptosis influence stroke pathology? Brain Pathol. 27, 205\u2013212 (2017).","journal-title":"Brain Pathol."},{"key":"5354_CR5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12975-018-0666-3","volume":"9","author":"S Chen","year":"2018","unstructured":"Chen, S. et al. Gasdermin family: a promising therapeutic target for stroke. Transl. Stroke Res. 9, 555\u2013563 (2018).","journal-title":"Transl. Stroke Res."},{"key":"5354_CR6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.coi.2013.12.002","volume":"26","author":"BA Croker","year":"2014","unstructured":"Croker, B. A., O\u2019Donnell, J. A. & Gerlic, M. Pyroptotic death storms and cytopenia. Curr. Opin. Immunol. 26, 128\u2013137 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"5354_CR7","first-page":"5823823","volume":"2018","author":"YL Gao","year":"2018","unstructured":"Gao, Y. L., Zhai, J. H. & Chai, Y. F. Recent advances in the molecular mechanisms underlying pyroptosis in sepsis. Mediators Inflamm. 2018, 5823823 (2018).","journal-title":"Mediators Inflamm."},{"key":"5354_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/bs.ai.2017.02.002","volume":"135","author":"X Liu","year":"2017","unstructured":"Liu, X. & Lieberman, J. A mechanistic understanding of pyroptosis: the fiery death triggered by invasive infection. Adv. Immunol. 135, 81\u2013117 (2017).","journal-title":"Adv. Immunol."},{"key":"5354_CR9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrn3638","volume":"15","author":"JG Walsh","year":"2014","unstructured":"Walsh, J. G., Muruve, D. A. & Power, C. Inflammasomes in the CNS. Nat. Rev. Neurosci. 15, 84\u201397 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"5354_CR10","doi-asserted-by":"crossref","unstructured":"Voet S., Srinivasan S., Lamkanfi M., van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol. Med. 11, e10248 (2019).","DOI":"10.15252\/emmm.201810248"},{"key":"5354_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"Bergsbaken, T., Fink, S. L. & Cookson, B. T. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7, 99\u2013109 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"5354_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi, J., Gao, W. & Shao, F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42, 245\u2013254 (2017).","journal-title":"Trends Biochem. Sci."},{"key":"5354_CR13","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1462-5822.2006.00751.x","volume":"8","author":"SL Fink","year":"2006","unstructured":"Fink, S. L. & Cookson, B. T. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol. 8, 1812\u20131825 (2006).","journal-title":"Cell Microbiol"},{"key":"5354_CR14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-021-03218-7","volume":"591","author":"N Kayagaki","year":"2021","unstructured":"Kayagaki, N. et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 591, 131\u2013136 (2021).","journal-title":"Nature"},{"key":"5354_CR15","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/eji.201646647","volume":"46","author":"I Jorgensen","year":"2016","unstructured":"Jorgensen, I., Lopez, J. P., Laufer, S. A. & Miao, E. A. IL-1beta, IL-18, and eicosanoids promote neutrophil recruitment to pore-induced intracellular traps following pyroptosis. Eur. J. Immunol. 46, 2761\u20132766 (2016).","journal-title":"Eur. J. Immunol."},{"key":"5354_CR16","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.immuni.2019.04.003","volume":"50","author":"C Wu","year":"2019","unstructured":"Wu, C. et al. Inflammasome activation triggers blood clotting and host death through pyroptosis. Immunity 50, 1401\u20131411 e1404 (2019).","journal-title":"Immunity"},{"key":"5354_CR17","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18443-3","volume":"11","author":"A Volchuk","year":"2020","unstructured":"Volchuk, A., Ye, A., Chi, L., Steinberg, B. E. & Goldenberg, N. M. Indirect regulation of HMGB1 release by gasdermin D. Nat. Commun. 11, 4561 (2020).","journal-title":"Nat. Commun."},{"key":"5354_CR18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/ni.2913","volume":"15","author":"BS Franklin","year":"2014","unstructured":"Franklin, B. S. et al. The adaptor ASC has extracellular and \u2018prionoid\u2019 activities that propagate inflammation. Nat. Immunol. 15, 727\u2013737 (2014).","journal-title":"Nat. Immunol."},{"key":"5354_CR19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas, C. et al. Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer\u2019s disease. Nature 552, 355\u2013361 (2017).","journal-title":"Nature"},{"key":"5354_CR20","doi-asserted-by":"crossref","first-page":"711939","DOI":"10.3389\/fimmu.2021.711939","volume":"12","author":"X Zheng","year":"2021","unstructured":"Zheng, X., Chen, W., Gong, F., Chen, Y. & Chen, E. The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review. Front Immunol. 12, 711939 (2021).","journal-title":"Front Immunol."},{"key":"5354_CR21","doi-asserted-by":"crossref","unstructured":"Caseley, E. A., Poulter, J. A. & Rodrigues, F. Immunome Project Consortium for Autoinflammatory D, McDermott MF. Inflammasome inhibition under physiological and pharmacological conditions. Genes Immun. 21, 211\u2013223 (2020).","DOI":"10.1038\/s41435-020-0104-x"},{"key":"5354_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13543776.2017.1378426","volume":"28","author":"H Lee","year":"2018","unstructured":"Lee, H. et al. Caspase inhibitors: a review of recently patented compounds (2013-2015). Expert Opin. Ther. Pat. 28, 47\u201359 (2018).","journal-title":"Expert Opin. Ther. Pat."},{"key":"5354_CR23","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1016\/j.celrep.2017.12.018","volume":"21","author":"KS Schneider","year":"2017","unstructured":"Schneider, K. S. et al. The inflammasome drives GSDMD-independent secondary pyroptosis and IL-1 release in the absence of caspase-1 protease activity. Cell Rep. 21, 3846\u20133859 (2017).","journal-title":"Cell Rep."},{"key":"5354_CR24","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1559-4","volume":"10","author":"WP Loomis","year":"2019","unstructured":"Loomis, W. P., den Hartigh, A. B., Cookson, B. T. & Fink, S. L. Diverse small molecules prevent macrophage lysis during pyroptosis. Cell Death Dis. 10, 326 (2019).","journal-title":"Cell Death Dis."},{"key":"5354_CR25","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1002\/cpim.52","volume":"122","author":"AB den Hartigh","year":"2018","unstructured":"den Hartigh, A. B. & Fink, S. L. Pyroptosis INduction and Detection. Curr. Protoc. Immunol. 122, e52 (2018).","journal-title":"Curr. Protoc. Immunol."},{"key":"5354_CR26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.celrep.2016.06.011","volume":"16","author":"TC Tzeng","year":"2016","unstructured":"Tzeng, T. C. et al. A fluorescent reporter mouse for inflammasome assembly demonstrates an important role for cell-bound and free ASC specks during in vivo infection. Cell Rep. 16, 571\u2013582 (2016).","journal-title":"Cell Rep."},{"key":"5354_CR27","doi-asserted-by":"crossref","first-page":"17070","DOI":"10.1038\/cddiscovery.2017.70","volume":"3","author":"L DiPeso","year":"2017","unstructured":"DiPeso, L., Ji, D. X., Vance, R. E. & Price, J. V. Cell death and cell lysis are separable events during pyroptosis. Cell Death Discov. 3, 17070 (2017).","journal-title":"Cell Death Discov."},{"key":"5354_CR28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4049\/jimmunol.1600699","volume":"197","author":"HM Russo","year":"2016","unstructured":"Russo, H. M. et al. Active caspase-1 induces plasma membrane pores that precede pyroptotic lysis and are blocked by lanthanides. J. Immunol. 197, 1353\u20131367 (2016).","journal-title":"J. Immunol."},{"key":"5354_CR29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-021-03478-3","volume":"593","author":"S Xia","year":"2021","unstructured":"Xia, S. et al. Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature 593, 607\u2013611 (2021).","journal-title":"Nature"},{"key":"5354_CR30","doi-asserted-by":"crossref","first-page":"779432","DOI":"10.3389\/fcell.2021.779432","volume":"9","author":"S Dai","year":"2021","unstructured":"Dai, S. et al. GSDMD mediates LPS-induced septic myocardial dysfunction by regulating ROS-dependent NLRP3 inflammasome activation. Front. Cell Dev. Biol. 9, 779432 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"5354_CR31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666\u2013671 (2015).","journal-title":"Nature"},{"key":"5354_CR32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117\u2013121 (2011).","journal-title":"Nature"},{"key":"5354_CR33","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana, S., Manrique-Caballero, C. L., Gomez, H. & Kellum, J. A. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 96, 1083\u20131099 (2019).","journal-title":"Kidney Int"},{"key":"5354_CR34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s43141-021-00224-0","volume":"19","author":"A Ghit","year":"2021","unstructured":"Ghit, A., Assal, D., Al-Shami, A. S. & Hussein, D. E. E. GABAA receptors: structure, function, pharmacology, and related disorders. J. Genet. Eng. Biotechnol. 19, 123 (2021).","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"5354_CR35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/tcr.10040","volume":"2","author":"P Krogsgaard-Larsen","year":"2002","unstructured":"Krogsgaard-Larsen, P., Frolund, B. & Liljefors, T. Specific GABA(A) agonists and partial agonists. Chem. Rec. 2, 419\u2013430 (2002).","journal-title":"Chem. Rec."},{"key":"5354_CR36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1471-4159.1975.tb04411.x","volume":"25","author":"P Krogsgaard-Larsen","year":"1975","unstructured":"Krogsgaard-Larsen, P., Johnston, G. A., Curtis, D. R., Game, C. J. & McCulloch, R. M. Structure and biological activity of a series of conformationally restricted analogues of GABA. J. Neurochem. 25, 803\u2013809 (1975).","journal-title":"J. Neurochem."},{"key":"5354_CR37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1471-4159.1978.tb10469.x","volume":"30","author":"P Krogsgaard-Larsen","year":"1978","unstructured":"Krogsgaard-Larsen, P. & Johnston, G. A. Structure-activity studies on the inhibition of GABA binding to rat brain membranes by muscimol and related compounds. J. Neurochem. 30, 1377\u20131382 (1978).","journal-title":"J. Neurochem."},{"key":"5354_CR38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/jm049256w","volume":"48","author":"B Frolund","year":"2005","unstructured":"Frolund, B. et al. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling. J. Med. Chem. 48, 427\u2013439 (2005).","journal-title":"J. Med. Chem."},{"key":"5354_CR39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4899-5199-1_18","volume":"123","author":"P Krogsgaard-Larsen","year":"1979","unstructured":"Krogsgaard-Larsen, P., Krogsgaard-Larsen, P., Arnt, J. & Arnt, J. GABA receptor agonists: relationship between structure and biological activity in vivo and in vitro. Adv. Exp. Med. Biol. 123, 303\u2013321 (1979).","journal-title":"Adv. Exp. Med. Biol."},{"key":"5354_CR40","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.biomaterials.2004.06.007","volume":"26","author":"TQ Vu","year":"2005","unstructured":"Vu, T. Q. et al. Activation of membrane receptors by a neurotransmitter conjugate designed for surface attachment. Biomaterials 26, 1895\u20131903 (2005).","journal-title":"Biomaterials"},{"key":"5354_CR41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/jm301473k","volume":"56","author":"JG Petersen","year":"2013","unstructured":"Petersen, J. G. et al. Synthesis and biological evaluation of 4-(aminomethyl)-1-hydroxypyrazole analogues of muscimol as gamma-aminobutyric acid(a) receptor agonists. J. Med. Chem. 56, 993\u20131006 (2013).","journal-title":"J. Med. Chem."},{"key":"5354_CR42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41586-023-05991-z","volume":"618","author":"M Degen","year":"2023","unstructured":"Degen, M. et al. Structural basis of NINJ1-mediated plasma membrane rupture in cell death. Nature 618, 1065\u20131071 (2023).","journal-title":"Nature"},{"key":"5354_CR43","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.febslet.2009.10.022","volume":"584","author":"G Drin","year":"2010","unstructured":"Drin, G. & Antonny, B. Amphipathic helices and membrane curvature. FEBS Lett. 584, 1840\u20131847 (2010).","journal-title":"FEBS Lett."},{"key":"5354_CR44","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00003246-200106000-00024","volume":"29","author":"S Yang","year":"2001","unstructured":"Yang, S., Koo, D. J., Chaudry, I. H. & Wang, P. Glycine attenuates hepatocellular depression during early sepsis and reduces sepsis-induced mortality. Crit. Care Med. 29, 1201\u20131206 (2001).","journal-title":"Crit. Care Med."},{"key":"5354_CR45","first-page":"G97","volume":"271","author":"K Ikejima","year":"1996","unstructured":"Ikejima, K., Iimuro, Y., Forman, D. T. & Thurman, R. G. A diet containing glycine improves survival in endotoxin shock in the rat. Am. J. Physiol. 271, G97\u2013G103 (1996).","journal-title":"Am. J. Physiol."},{"key":"5354_CR46","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jss.2013.01.024","volume":"183","author":"T Hamburger","year":"2013","unstructured":"Hamburger, T. et al. Effects of glycine, pyruvate, resveratrol, and nitrite on tissue injury and cytokine response in endotoxemic rats. J. Surg. Res. 183, e7\u2013e21 (2013).","journal-title":"J. Surg. Res."},{"key":"5354_CR47","doi-asserted-by":"crossref","unstructured":"Borges, J. P. et al. Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. Elife 11, e78609 (2022).","DOI":"10.7554\/eLife.78609"},{"key":"5354_CR48","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41586-023-06191-5","volume":"618","author":"N Kayagaki","year":"2023","unstructured":"Kayagaki, N. et al. Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury. Nature 618, 1072\u20131077 (2023).","journal-title":"Nature"},{"key":"5354_CR49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/SHK.0b013e31822f7e58","volume":"36","author":"S Sugiura","year":"2011","unstructured":"Sugiura, S. et al. Valproic acid increases susceptibility to endotoxin shock through enhanced release of high-mobility group box 1. Shock 36, 494\u2013500 (2011).","journal-title":"Shock"},{"key":"5354_CR50","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1471-4159.2001.00124.x","volume":"76","author":"Q Shan","year":"2001","unstructured":"Shan, Q., Haddrill, J. L. & Lynch, J. W. A single beta subunit M2 domain residue controls the picrotoxin sensitivity of alphabeta heteromeric glycine receptor chloride channels. J. Neurochem. 76, 1109\u20131120 (2001).","journal-title":"J. Neurochem."},{"key":"5354_CR51","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1021\/jm00100a015","volume":"35","author":"A Melikian","year":"1992","unstructured":"Melikian, A., Schlewer, G., Chambon, J. P. & Wermuth, C. G. Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists. J. Med. Chem. 35, 4092\u20134097 (1992).","journal-title":"J. Med. Chem."},{"key":"5354_CR52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3727\/105221615X14181438356337","volume":"16","author":"W Masocha","year":"2015","unstructured":"Masocha, W. Comprehensive analysis of the GABAergic system gene expression profile in the anterior cingulate cortex of mice with Paclitaxel-induced neuropathic pain. Gene Expr. 16, 145\u2013153 (2015).","journal-title":"Gene Expr."},{"key":"5354_CR53","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-7-233","volume":"7","author":"B Shrum","year":"2014","unstructured":"Shrum, B. et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res. Notes 7, 233 (2014).","journal-title":"BMC Res. Notes"}],"updated-by":[{"DOI":"10.1038\/s42003-024-05975-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000}}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05354-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05354-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05354-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T04:05:36Z","timestamp":1710216336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05354-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5354"],"URL":"https:\/\/doi.org\/10.1038\/s42003-023-05354-4","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"assertion":[{"value":"3 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s42003-024-05975-3","URL":"https:\/\/doi.org\/10.1038\/s42003-024-05975-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1010"}}